Partner Content Partner Content Q&A Released with West Pharmaceutical Services ahead of ... Interview released with West Pharmaceutical Services
Partner Content Partner Content MHRA to Open 10th Annual European Summit on Pre-Filled Syrin... MHRA to open PFS Europe 2018
News Could a Novo error set up early GLP-1 generics in Canada? Reports say Novo Nordisk may have inadvertently let generics of its GLP-1 drug semaglutide for diabetes and obesity launch in Canada early next year.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
